02254nas a2200241   4500000000100000008004100001260007600042653001200118653001100130653001500141653002400156653002500180653002100205100002800226700003100254700002700285245010500312300001200417490000700429520154800436022001401984020001401998       2024                            d  c12/2024bSociedad Española para el Estudio de la Ansiedad y el Estrés10aAnxiety10aStress10aSmartphone10amobile applications10adigital intervention10aworkplace stress1 aJuan José Miguel Tobal1 aM.ª Isabel Casado Morales1 aJuliana Beatriz Stover00aReducing Stress Levels and Anxiety Symptoms Through the Use of a Mobile Application in the Workplace  a123-1290 v303 aThe use of mobile applications to reduce anxiety and stress levels is under development. Neuromify is an application designed in Spain to reduce these levels in the work context. This research analyzes the effectiveness of its implementation. The sample consisted of 76 workers (59.2% men, 40.8% women; Mage=43.20; SDage=9.75). Data were collected with a sociodemographic survey, the Inventory of Anxiety Situations and Responses, Version B (ISRA-B), and the Perceived Stress Scale (PSS). The sample consisted of 76 workers (59.2% male; 40.8% female; Mage=43.20; SDage=9.75). Sociodemographic variables (gender, job category, incentives) and the initial level of anxiety and stress were analyzed to examine whether adherence to the program was linked to any of these variables. A significant association was only found in the incentives variable, with a higher frequency of subjects completing the program among those who received incentives. Student t tests for repeated measures were performed comparing the levels of anxiety and stress at the beginning and end of the program. Significant differences were found, with lower means at the end of the program. The effect sizes were greater for the group of subjects with greater anxiety at the beginning of the program. In conclusion, this work demonstrates the effectiveness of Neuromify in reducing stress levels and anxiety symptoms in the work context. In conclusion, this work demonstrates the effectiveness of Neuromify in reducing stress levels and anxiety symptoms in the work context.  a1134-7937  a2174-0437